Moderate Asthma

Sandhya Khurana, MD, FCCP, spoke with Healio about key takeaways from the CHEST Annual Meeting that she plans to incorporate into her practice.

In this video, Sandhya Khurana, MD, FCCP, discusses highlights from her presentation on advances in severe asthma at CHEST Annual Meeting.

Data from the PRACTICAL study showed that budesonide-formoterol reliever therapy in a single inhaler for patients with mild to moderate asthma was associated with a 31% reduction in the risk for severe exacerbations, as compared with maintenance budesonide plus terbutaline reliever therapy.